Author

G. Y. Lopez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. M. Ashley· 2 shared D. D. Bigner· 1 shared E. M. Thompson· 1 shared G. Zhang· 1 shared J. A. Regal· 1 shared K. Stevenson· 1 shared M. C. Brown· 1 shared M. E. Guerra Garcia· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. M. Ashley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population

J. A. Regal, M. E. Guerra Garcia, V. Jain, V. Chandramohan, D. M. Ashley, S. G. Gregory, E. M. Thompson, G. Y. Lopez, Z. J. Reitman

This study uses deep transcriptomic analyses to identify a CD34+ neuroectoderm-like population in gangliogliomas, revealing its role as a precursor cell controlling tumor heterogeneity and immune interactions.

Acta Neuropathologica Communications · Mar 25, 2023Peer-reviewedCancer Biology

Polio Virotherapy of Malignant Glioma Engages the Tumor Myeloid Infiltrate and Induces Diffuse Microglia Activation

Y. Yang, M. C. Brown, G. Zhang, K. Stevenson, M. Mohme, R. Kornahrens, D. D. Bigner, D. M. Ashley, G. Y. Lopez, M. Gromeier

This study investigates how PVSRIPO virotherapy activates microglia and myeloid cells in gliomas, leading to antitumor inflammation and improved outcomes when combined with PD1/PD-L1 blockade.

bioRxiv · Apr 19, 2022 · PreprintCancer Biology